Barclays Bank PLC (the “Issuer”) announced today that, in connection with its previously announced cash tender offers (each, ...

Teoxane, which holds a 6.2% stake in Revance and is a key customer of the Nashville, Tenn., company, had proposed buying the rest of the company for $3.60 a share after Crown reduced its planned ...

Emerson will acquire all outstanding shares of common stock of AspenTech not already owned by Emerson for $265/share pursuant to an all-cash tender offer. The transaction values the minority stake ...

SoftBank is in talks to invest up to $25 billion in OpenAI, which would make it the company’s biggest backer, CNBC has ...

Teoxane withdrew its $3.60 a share offer for Revance Therapeutics after Crown Labs raised its offer to $3.65. Revance ticked lower by 0.3% in premarket trading. Teoxane said that committed financing ...

According to a recent Bloomberg broadcast, SpaceX is now valued at about $350 billion (€336.2bn). This value has been ...

Securities maintained its Neutral rating on Revance Therapeutics (NASDAQ:RVNC) with a steady price target of $3.65, closely ...

Group sales grew by 7%1 at constant exchange rates (CER; 3% in CHF), driven by strong demand for both medicines and diagnostics.Excluding COVID-19, Group sales increased by 9%.

The Scottish government’s hunt for a financial adviser for the nation’s debut bond sale is proving more costly than ...

The Scottish government’s hunt for a financial adviser for the nation’s debut bond sale is proving more costly than ...

Fields' age might make him more appealing to other teams. Meanwhile, the Steelers have six other starters set to hit the ...